BMGLNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends June 30
Basel Medical Group Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 18, 2025
$4.05+0.10 (+2.53%)
Close on Oct 19, 2026
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Basel Medical has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Basel Medical filed with the SEC
Medical Group Ltd (BMGL) Closes Registered Direct Offering
EX-99.1 to Form 6-K
Medical Group Ltd (BMGL) Prices Registered Direct Offering
EX-99.1 to Form 6-K
Regains Compliance With Nasdaq Minimum Bid Price Requirement
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
EX-99.2 to Form 6-K
to Effect Reverse Share Split on June 22, 2026
EX-99.1 to Form 6-K
With Nasdaq Periodic Filing Requirement
EX-99.1 to Form 6-K
of Delinquency Notification from Nasdaq
EX-99.1 to Form 6-K
Receipt of Delinquency Notification from Nasdaq
EX-99.1 to Form 6-K
We have read the statement made by Basel Medical Group Ltd pursuant
EX-99.1 to Form 6-K
Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising
EX-99.1 to Form 6-K
Medical Group Ltd and its Subsidiaries
EX-99.1 to Form 6-K
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
EX-99.2 to Form 6-K
Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility
EX-99.1 to Form 6-K
AGREEMENT (“AGREEMENT”) is made on the 20 day of May 2025.
EX-99.2 to Form 6-K
Medical Group Ltd Announces Exercise of Overallotment Option
EX-99.1 to Form 6-K
Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public
EX-99.1 to Form 6-K
Medical Group Ltd Prices US$8,820,000 Initial Public Offering
EX-99.1 to Form 6-K